Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | AZD6918 |
| Synonyms | |
| Therapy Description |
AZD6918 is a selective TRK receptor inhibitor, which potentially leads to increased tumor cell death (PMID: 25700942, PMID: 28230291). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| AZD6918 | Trk Receptor Inhibitor (Pan) 33 | AZD6918 is a selective TRK receptor inhibitor, which potentially leads to increased tumor cell death (PMID: 25700942, PMID: 28230291). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| NTRK2 wild-type | Advanced Solid Tumor | sensitive | AZD6918 | Preclinical | Actionable | In a preclinical study, AZD6918 treatment inhibited Ntrk2 autophosphorylation and BDNF-induced cell proliferation of transformed cell lines expressing wild-type Ntrk2 in culture (PMID: 21242122). | 21242122 |
| NTRK2 R734C | Advanced Solid Tumor | resistant | AZD6918 | Preclinical | Actionable | In a preclinical study, a transformed cell line expressing NTRK2 R734C was resistant to inhibition of Ntrk2 autophosphorylation and BDNF-induced cell proliferation by AZD6918 treatment in culture (PMID: 21242122). | 21242122 |
| NTRK2 M713I | Advanced Solid Tumor | resistant | AZD6918 | Preclinical | Actionable | In a preclinical study, a transformed cell line expressing NTRK2 M713I was resistant to inhibition of Ntrk2 autophosphorylation and BDNF-induced cell proliferation by AZD6918 treatment in culture (PMID: 21242122). | 21242122 |
| NTRK2 R715G | Advanced Solid Tumor | resistant | AZD6918 | Preclinical | Actionable | In a preclinical study, a transformed cell line expressing NTRK2 R715G was resistant to inhibition of Ntrk2 autophosphorylation and BDNF-induced cell proliferation by AZD6918 treatment in culture (PMID: 21242122). | 21242122 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|